Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia

Leuk Lymphoma. 2022 Jul;63(7):1714-1717. doi: 10.1080/10428194.2022.2045599. Epub 2022 Apr 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Drug Resistance, Neoplasm
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Intracranial Hypertension*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
  • Protein Kinase Inhibitors / adverse effects

Substances

  • Protein Kinase Inhibitors
  • Fusion Proteins, bcr-abl